Valuations of all the megatech stocks have fallen, but Alphabet still isn't cheap enough. It's getting there, and she's watching it (along with Netflix, Amazon). She hasn't owned these stocks in years, but share prices could fall low enough for her to enter.
She wishes that today's upgrade had come earlier. 2023 earnings will be flat, not great, but they have some new drugs will drive earnings in the future. This stock could do nothing for a while, but nothing wrong to hold it; earnings may stay flat.
She's not a fan of ETFs, this single-brushstroke style of investing, but an ETF makes sense in health care, because the companies are very different. Some will excel while others will flame out (considering their drug pipelines).
Cloud computing growth across many companies is projected to slow as cloud matures, but IBM's underlying legacy business remains a huge grower and will comprise their revenues more and more. Will drive valuation from 14x to 16x, and still deserves discounted valuation vs. peers, though this discount is overlooked by the market.
Not cheap at 24x PE, but the company is entering a mature phase. In 10 years, we will look at high-growth megatechs as industrials or utilities. Given this maturity, we need to re-rate this group.
Down over 40% in the past year. Pays a 7.7% dividend. Expects it to produce $3 of earnings. Is priced now as if the consumer will lie down and down--not the case.
2022 will be the fourth-worst year since 1945 and the worst since 2008, BUT the market tends to avoid back-to-back down years. The S&P was 20% this year. The best thing about 2022 was that expectation were reset to reasonable so that investors are more rational. This portends well for the next 3-5 years. In the decade before 2021, the market returned 16.5% annually. Everyone is so miserable this year, but remember you gained a lot in 2020 and 2021. So a 6-7% return next year is fine. However, her biggest concern for 2023 is that earnings come in worse than the market currently expects.
Just bought it. Stock is down 40% this year. In 2021, they started to jack the dividend up, now paying a 4.1% dividend and trades at 11.6x. Peers like AutoZone trade around 20-26x PE. They will be resilient in a tough economy where you can delay buying a car, but you will always need to pay for repairs and auto parts. Earnings, though, will stay flat next year, she thinks. Solid and better than a bond.